2015
Transmission risk behaviour at enrolment in participants in the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial
Rodger A, Lampe F, Grulich A, Fisher M, Friedland G, Phanuphak N, Bogner, Pereira L, Rietmeijer C, Burman W, Phillips A, Group I. Transmission risk behaviour at enrolment in participants in the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial. HIV Medicine 2015, 16: 64-76. PMID: 25711325, PMCID: PMC4341939, DOI: 10.1111/hiv.12235.Peer-Reviewed Original ResearchConceptsAntiretroviral treatmentCondomless sexHIV-1 RNA copies/Risk behaviorsRegion of recruitmentSelf-reported risk behaviorsHIV viral loadHIV-positive participantsRNA copies/Transmission risk behaviorsHIV-positive peopleSubstantial proportionRecent sexual behaviorHeterosexual menSerodifferent partnersMedian ageRisk behavior questionnaireViral loadClinical statusLifestyle factorsBlack ethnicityCopies/Trial participantsStart StudyWhite ethnicity
1987
Febrile inpatients
Makadon H, Bor D, Friedland G, Dasse P, Komaroff A, Aronson M. Febrile inpatients. Journal Of General Internal Medicine 1987, 2: 293-297. PMID: 3655954, DOI: 10.1007/bf02596161.Peer-Reviewed Original ResearchConceptsLikelihood of bacteremiaBlood culturesMedical inpatientsHouse officersCause of feverOnset of feverEpisodes of feverCases of bacteremiaFebrile episodesFebrile patientsBacteremic patientsFever episodesFebrile inpatientsBacteremic episodesBacteremiaClinical judgmentFeverBacterial infectionsMedical house officersInpatientsEpisodesPatientsBloodSets of culturesAdequate substitute